Search

Author/Creator Martin, Jason

7. Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults. Issue 9 (2nd September 2019)

Authors:
Manoff, Susan B.; Sausser, Michele; Falk Russell, Amy; Martin, Jason; Radley, David; Hyatt, Donna; Roberts, Christine C.; Lickliter, Jason; Krishnarajah, Janakan; Bett, Andrew; Dubey, Sheri; Finn, Tyler; Coller, Beth-Ann
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 15:Issue 9(2019)
Page Start:
2195
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults. (18th July 2019)

Authors:
Halperin, Scott A; Das, Rituparna; Onorato, Matthew T; Liu, Kenneth; Martin, Jason; Grant-Klein, Rebecca J; Nichols, Rick; Coller, Beth-Ann; Helmond, Frans A; Simon, Jakub K
Journal:
Journal of infectious diseases
Issue:
Volume 220:Number 7(2019)
Page Start:
1127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Immunogenicity, Lot Consistency, and Extended Safety of rVSVΔG-ZEBOV-GP Vaccine: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study in Healthy Adults. (18th July 2019)

Authors:
Halperin, Scott A; Das, Rituparna; Onorato, Matthew T; Liu, Kenneth; Martin, Jason; Grant-Klein, Rebecca J; Nichols, Rick; Coller, Beth-Ann; Helmond, Frans A; Simon, Jakub K
Journal:
Journal of infectious diseases
Issue:
Volume 220:Number 7(2019)
Page Start:
1127
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗